CTAGE1 Activators are a group of chemical compounds that play a crucial role in enhancing the functional activity of CTAGE1, a protein involved in various cellular processes. These activators exert their influence by targeting specific signaling pathways and biological processes, ultimately leading to the activation of CTAGE1. Forskolin, for example, acts as an activator by increasing intracellular cAMP levels, indirectly enhancing CTAGE1's functional role. Genistein, on the other hand, achieves activation through tyrosine kinase inhibition, allowing CTAGE1 pathways to operate more effectively. These activators contribute to the regulation of cellular adhesion processes and other functions in which CTAGE1 is involved, making them valuable tools for studying and modulating CTAGE1 activity.
In addition to these direct activators, CTAGE1 activation is further facilitated by compounds like Sphingosine-1-phosphate and Thapsigargin, which modulate lipid signaling and calcium-dependent pathways, respectively. These actions potentiate the cellular adhesion processes in which CTAGE1 plays a vital role. Moreover, activators like PMA, Epigallocatechin gallate, LY294002, and Wortmannin promote CTAGE1 activation by influencing specific signaling pathways, ensuring that CTAGE1-related functions are enhanced without the need for upregulating its expression. Additionally, SB203580 and U0126 modulate MAPK signaling pathways, shifting the signaling equilibrium towards pathways associated with CTAGE1, further promoting its activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates CTAGE1 by increasing intracellular cAMP levels, indirectly enhancing CTAGE1's functional role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein activates CTAGE1 through tyrosine kinase inhibition, allowing CTAGE1 pathways to be more active. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate modulates lipid signaling, potentiating cellular adhesion processes involving CTAGE1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin influences calcium signaling, enhancing CTAGE1's role in calcium-dependent cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that contributes to CTAGE1 activation by promoting adhesion-related pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate acts as a kinase inhibitor, enhancing CTAGE1 activation by reducing competitive signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 activates CTAGE1 by inhibiting PI3K, thereby promoting pathways associated with CTAGE1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin activates CTAGE1 through PI3K inhibition, leading to increased functional activity of CTAGE1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38, modulating MAPK signaling and shifting the equilibrium towards CTAGE1-related pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 enhances CTAGE1's activity by increasing intracellular calcium levels, activating calcium-dependent pathways. | ||||||